3'-N3-5'-O-Bz-ddT
3'-N3-5'-O-Bz-ddT - N (Normal) is backordered and will ship as soon as it is back in stock.
Couldn't load pickup availability
Shipping notes
Shipping notes
Related Products
Specifications
Specifications
-
Catalog No.D4-003
-
SMILESO=C(C(C)=CN1[C@H]2C[C@H](N=[N+]=[N-])[C@@H](COC(C3=CC=CC=C3)=O)O2)NC1=O
-
Molecular FormulaC17H17N5O5
-
Molecular Weight371.35
-
AppearanceOff-white to yellow powder
-
PurityHPLC≥98.0%
-
Storage Condition2-8℃, Keep in a dark and dry place
Documentation
Documentation
-
Catalog No.D4-003
-
SMILESO=C(C(C)=CN1[C@H]2C[C@H](N=[N+]=[N-])[C@@H](COC(C3=CC=CC=C3)=O)O2)NC1=O
-
Molecular FormulaC17H17N5O5
-
Molecular Weight371.35
-
AppearanceOff-white to yellow powder
-
PurityHPLC≥98.0%
-
Storage Condition2-8℃, Keep in a dark and dry place
Why choose Hongene?
Trusted Partner in Nucleic Acid
Integrated Supply & Commercial Scale
With 26+ years of expertise, we control a secure supply chain for RNA raw materials and provide reliable GMP-grade oligo synthesis from research to commercial kilogram-scale production.
Proprietary Technology & IP
Our proprietary Chemoenzymatic Ligation Platform combines chemical andenzymatic methods, enabling high-putity, cost-effective, and large-scale production of RNA-based therapeutics.
Rigorous Quality
We implement multiple stringent QC steps, maintain ISO certifications, and ensure >99% batch-to-batch consistency, reducing scale-up and PPQ risks.
Manufacturing Scalability
Hongene operates 1.67 million sq. ft Oligonucleotide Manufacturing Facility, with advanced equipments including multiple OligoPilot™ and OligoProcess™ synthesizers (10-1800 mmol). 48 flexible production lines enable one-stop seamless scaling-up of API production from gram-level to tons and acheive high purity of 98%, meeting NMPA, FDA, and EMA standards.
Global Business Network
Our products and services reach over 40 countries and regions, supporting around 3,000 clients worldwide.
